Cognition Therapeutics retweeted
Wonderful to hear from #biotech and @pharma leaders on strategies to accelerate #drugdevelopment. Thank you @LisaRRicciardi @CogRx, @ShivaMalek @Novartis, Phil Vickers @Solu_Tx, @anirvan0419 @unitybiotech, Carl Hansen @AbCelleraBio
Cognition Therapeutics retweeted
Enhanced Cognition: Lewy body dementia phase II pumps stock bioworld.com/articles/715450 #biotech #pharma @CogRx
Cognition Therapeutics retweeted
In results presented at #CTAD2024, treatment with #CT1812, an experimental oral small molecule, was associated with a 95% slowing in #cognitive decline for people with #Alzheimer disease.
practicalneurology.com/news/…
@CTADconference @alzassociation @CogRx
Cognition Therapeutics retweeted
🫣📹Here is a sneak peek at the interview we did with Michael Woodward, MD, FRACP, head of dementia research at @Austin_Health, and Anthony Caggiano, MD, PhD, CMO at @CogRx, who both shared their perspective on the latest presentations in #Alzheimers at #CTAD24! @CTADconference
Cognition Therapeutics retweeted
We are #StrongerTogether when we...
🔬 ACCELERATE research advancements
📚 INCREASE the understanding of #Lewybodydementia
👥 CREATE connections by providing compassionate support
💜 CONTINUE to increase awareness and raise funds
Get involved at ow.ly/us2t50TACG4
Cognition Therapeutics retweeted
LBDA, in collaboration with the Alzheimer’s Association, is bringing the dementia with Lewy bodies (DLB) community together for the Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting on DLB.
This is your two-week reminder! 🕐 RSVP at ow.ly/h9l850TF1lf
Cognition Therapeutics retweeted
“What is #Lewybodydementia?” A question many have been asked by friends, family members, and acquaintances. Though it affects over 1.4 million Americans, few are aware of the symptoms, diagnostic criteria, or that it even exists.
Learn more at ow.ly/rZCY50QI2gz
Cognition Therapeutics retweeted
A phase 2 study showed that treatment with investigational CT1812 resulted in improved established #EEG markers of spontaneous brain activity in patients with mild-to-moderate #AlzheimerDisease. @CogRx
neurologylive.com/view/ct181…
Cognition Therapeutics retweeted
Anthony Caggiano, MD, PhD, CMO at @CogRx, provided clinical insight on new phase 2 data and the mechanism of action of CT1812, a therapy in development for Alzheimer disease🧠
Watch here: neurologylive.com/view/suppo…
Cognition Therapeutics retweeted
#TheLongestDay ☀️ is here! Help us cheer 📣 on all those fighting the darkness of Alzheimer’s. Follow along as we share inspiring stories throughout the day, and check out participant photos at alz.org/ShineALight. #ENDALZ
Cognition Therapeutics retweeted
Join us at @LongwoodFund Spring MIT to hear the latest in identifying next-generation therapeutics with @omarabudayyeh @MIT Carl Hansen @AbCelleraBio Joel Schneider @CarbonBiosci Bill Watt @AstellasUS & @LisaRRicciardi @CogRx. See the agenda: longwoodhealthcareleaders.co…
Cognition Therapeutics retweeted
Molecules of the Month – Feb. 2024
Actelion revealed the discovery story of nivasorexant, a selective orexin-1 receptor antagonist, which completed a Ph. II clinical trial in binge-eating disorder.
Check out our other top molecules from Feb.!
Article | drughunters.com/3vbzEDY
Cognition Therapeutics retweeted
.@CogRx adding $11.5M in public offering for Alzheimer’s drug bioworld.com/articles/706565 #biotech #pharma
Cognition Therapeutics retweeted
Yay our latest paper is out! TMEM97 and abeta are close enough to generate a FRET signal in human synapses. Led by amazing Dr Marti Colom-Cadena and a great collaboration with colleagues @CogRx link.springer.com/article/10…
Cognition Therapeutics retweeted
Join us on Sunday, January 28th, as we celebrate the 1st-ever World Lewy Body Day💙
#WLDB #LewyBodyDay
Cognition Therapeutics retweeted
San Francisco CEO convenes #BioPharma leaders the weekend prior to #JPM24 with a forum for industry leaders to discuss the state and future of the industry. This off-the-record #networking and brainstorming forum takes on January 6-7, 2024. See More: conta.cc/3QGV4Q4
Cognition Therapeutics retweeted
A breathtaking overhead view of The @EmpireStateBldg lit up in TEAL to mark Alzheimer's Awareness Month. Light the World in Teal is held each Nov to raise awareness and show support for the millions of people affected by Alzheimer’s.
lighttheworldinteal.com/
#Alzheimers #dementia
Cognition Therapeutics retweeted
As biopharma giants reshape Alzheimer's treatment, @CogRx insists there’s room for its lead pipeline candidate too. Read more: ow.ly/7pca50Q08N1
Cognition Therapeutics retweeted
🎉"October is Lewy Body Dementia Awareness Month. 👉We believe it is crucial to bring awareness to LBD so that people are diagnosed correctly. For LBD symptoms, see: lewybodyresourcecenter.org/w… 💜When you share our post, you help us bring awareness. Thank you!
Cognition Therapeutics retweeted
Don’t miss Dementia Friendly PA’s #Lewybodydementia webinar & screening of the Robin Williams documentary, SPARK, on 10/11. Learn how to define LBD and identify its symptoms.
Register today at ow.ly/CQVM50PUiIM
#LBDCommunity #LBDAwarenessMonth23



























